UTILITY STUDY IN DIFFUSE LARGE B-CELL LYMPHOMA
Research type
Research Study
Full title
UK UTILITY STUDY IN DIFFUSE LARGE B-CELL LYMPHOMA
IRAS ID
197111
Contact name
Catherine Bottomley
Contact email
Sponsor organisation
Roche Products Limited
Duration of Study in the UK
0 years, 9 months, 31 days
Research summary
This non interventional research study will involve patients who are in remission from Diffuse Large B-Cell Lymphoma (DLBCL). Approximately 100 patients will be recruited to the study using a combination of online adverts through a leading lymphoma charity and a specialist medical recruitment agency. Once the patient has been given information about the study, screened for eligibility and has consented, they will take a short 15 minute survey, either on-line or by post.
The aim of the study is to describe the quality of life of patients in remission from DLBCL using approved questionnaires developed to measure quality of life.
The data will be analysed by pH Associates (research consultancy).REC name
North West - Greater Manchester West Research Ethics Committee
REC reference
16/NW/0195
Date of REC Opinion
8 Mar 2016
REC opinion
Favourable Opinion